Back to Search
JOHN SRAMEK, PHARM.D.
PHARM.D.
Pharmacotherapy Pharmacist
NPI: 1952625923Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
RPH31194(CA)
Psychiatric Pharmacist
Pharmacist — Psychiatric
Code: 1835P1300X
RPH31194(CA)
Research & Publications (19)
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
PMID 11840225·J Hum Hypertens·2002
3-trial
The status of ongoing trials for mild cognitive impairment.
PMID 11281823·Expert Opin Investig Drugs·2001
6-review
Review of the acetylcholinesterase inhibitor galanthamine.
PMID 11060814·Expert Opin Investig Drugs·2000
6-review
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
PMID 14709949·J Clin Psychopharmacol·2004
3-trial
Clinical features predictive of successfully weaning from spectacles those children with accommodative esotropia.
PMID 12690363·J AAPOS·2003
8-other
Galantamine hydrobromide: an agent for Alzheimer's disease.
PMID 12635450·Am J Health Syst Pharm·2003
6-review
Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study.
PMID 12530340·Psychiatry·2002
3-trial
Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease.
PMID 11844244·Neurosurgery·2002
4-observational
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults.
PMID 11762563·J Clin Pharmacol·2001
3-trial
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease.
PMID 11583476·J Clin Pharmacol·2001
3-trial
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development.
PMID 11263756·Prog Neuropsychopharmacol Biol Psychiatry·2001
6-review
Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys.
PMID 11170732·Exp Neurol·2001
7-preclinical
Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?
PMID 11075302·J Clin Pharmacol·2000
8-other
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys.
PMID 10830419·Mov Disord·2000
7-preclinical
Gender differences in depression and antidepressant pharmacokinetics and adverse events.
PMID 10669189·Ann Pharmacother·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5031 SHORELINE WAY
OXNARD, CA 93035 - Phone
- (805) 984-3279
Quick Facts
- NPI
- 1952625923
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile